Physician profile
Anetta E Reszko
NPI 1114186400
$22,526.36
in general payments reported to CMS, 2019-2025
17 companies · $897 in 2025
The $897 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,189 · 2020: $10K · 2021: $6,506 · 2022: $809 · 2023: $317 · 2024: $426 · 2025: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,640.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $15,127.22 | 2019-2025 | Dysport, Oracea, Epsolay |
| Merz North America, INC. | $6,086.21 | 2019-2025 | Xeomin |
| Allergan, INC. | $594.80 | 2019-2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $139.55 | 2019-2025 | Fraxel, Clear & Brilliant |
| Abbvie INC. | $106.50 | 2025 | |
| Almirall LLC | $88.98 | 2021-2025 | Klisyri |
| Janssen Biotech, INC. | $79.62 | 2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $49.97 | 2025 | |
| Pfizer INC. | $47.66 | 2022-2023 | |
| Dermavant Sciences, INC. | $44.44 | 2023 | Vtama |
| Novartis Pharmaceuticals Corporation | $29.48 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $29.30 | 2025 | Dupixent |
| Leo Pharma INC. | $26.62 | 2025 | Adbry |
| Ucb, INC. | $24.97 | 2025 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $24.20 | 2025 | Zoryve |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Strata Skin Sciences, INC. | $15.26 | 2024 | Xtrac |
| Genentech USA, INC. | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anetta Reszko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.